CLASS II ONGOING Device recall · Reported 21 Jan 2026 · FDA Enforcement Report

Mosaiq Oncology Information System recalled by Elekta

Elekta is recalling Mosaiq Oncology Information System with Particle Therapy License (License Kit, distributed nationwide in the US. The recall was initiated on 10 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071
Quantity recalled1

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1078-2026
FDA event ID
98116
Recalling firm
Elekta, Atlanta, GA
Classification
Class II
Status
Ongoing
Recall initiated
10 Dec 2025
FDA classified
13 Jan 2026
Reported
21 Jan 2026
Type
Voluntary: Firm initiated
Reason category
Other Reasons
Device type
Medical Software

Timeline

10 Dec 2025Recall initiated by company
13 Jan 2026Classified by FDA+34 days
21 Jan 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice

Product as listed by the FDA

MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)

Where it was distributed

US Nationwide distribution in the state of TX.

Nationwide Texas

Questions about this recall

Is Mosaiq Oncology Information System with Particle Therapy License (License Kit recalled?

Yes. Elekta recalled Mosaiq Oncology Information System with Particle Therapy License (License Kit on 10 Dec 2025. The recall is Class II and its status is Ongoing. Recall number Z-1078-2026.

Why was it recalled?

Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice

Which lots are affected?

MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071

Where was it sold?

US Nationwide distribution in the state of TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Elekta

All 122

Other Medical Software recalls

All 903